Cargando…
E2F2 serves as an essential prognostic biomarker and therapeutic target for human renal cell carcinoma by presenting “E2F2/miR-16–5p/SPTLC1” schema
BACKGROUND: Renal cell carcinoma (RCC) is a common malignant tumor of the urinary system with high mortality and morbidity. Although E2F2, a classical transcription factor implicated in cell cycle, has been shown to foster tumorigenesis in several human cancers, it could not draw a satisfy answer re...
Autores principales: | Qu, GenYi, Yang, Guang, Chen, Dan, Tang, Cheng, Xu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302538/ https://www.ncbi.nlm.nih.gov/pubmed/37300925 http://dx.doi.org/10.1016/j.tranon.2023.101699 |
Ejemplares similares
-
Mutation screening of SPTLC1 and SPTLC2 in amyotrophic lateral sclerosis
por: Li, Chunyu, et al.
Publicado: (2023) -
E2F2/5/8 Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer
por: Zhou, Quan, et al.
Publicado: (2019) -
Prognostic analysis of E2F transcription factors E2F1 and E2F3 in four independent pediatric neuroblastoma cohorts
por: Wang, Haiwei, et al.
Publicado: (2022) -
E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter
por: Chu, Junjun, et al.
Publicado: (2015) -
Contrasting Roles of E2F2 and E2F3 in Cardiac Neovascularization
por: Zhou, Junlan, et al.
Publicado: (2013)